No difference found in drugs for macular degeneration
Friday, October 1, 2010 - 11:28
in Psychology & Sociology
Researchers have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration.